1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Treatment of marginal zone lymphoma
    Meeting Abstract

    Noy, A.
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • Primary mediastinal B-cell lymphoma
    Meeting Abstract

    Hamlin, P. A.
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • Timing of initiation of defibrotide post-diagnosis of hepatic veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) after hematopoietic stem cell transplantation (HSCT): Final data from an expanded-access protocol
    Meeting Abstract

    Richardson, P.; Smith, A.; Antin, J.; Lehmann, L.; Giralt, S.; Liang, W.; Hume, R.; Tappe, W.; Kernan, N.
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • Day+100 survival and safety results from a defibrotide expanded-access program for patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS): Final results
    Meeting Abstract

    Kernan, N.; Smith, A.; Antin, J.; Lehmann, L.; Giralt, S.; Ryan, R.; Hume, R.; Tappe, W.; Richardson, P.
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • Five-year efficacy and safety of dasatinib and imatinib by baseline comorbidity and age in patients with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP) from DASISION
    Meeting Abstract

    Mauro, M. J.; Cortes, J. E.; Hochhaus, A.; Shah, N. P.; Atallah, E. L.; Abaskharoun, M.; Sy, O.; Saglio, G.
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • Oral asciminib (ABL001) vs bosutinib in patients with chronic myeloid leukemia in chronic phase (CML-CP) who received ≥ 2 prior tyrosine kinase inhibitors (TKIs): A multicenter, open-label, randomized, phase 3 study
    Meeting Abstract

    Mauro, M.; Boquimpani, C.; Minami, Y.; Réa, D.; Kemp, C.; Hsu Schmitz, S. F.; Gopalakrishna, P.; Hochhaus, A.
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • Bosutinib (BOS) vs imatinib (IM) for newly diagnosed chronic myeloid leukemia (CML): Initial results from the BFORE trial
    Meeting Abstract

    Cortes, J.; Gambacorti-Passerini, C.; Deininger, M.; Mauro, M.; Chuah, C.; Kim, D. W.; Reilly, L.; Jeynes-Ellis, A.; Leip, E.; Bardy-Bouxin, N.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • Therapeutic TCR mimic monoclonal antibodies to intracellular oncogenic proteins
    Meeting Abstract

    Scheinberg, D. A.
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • Trial in progress: A Phase I/II study of lintuzumab-Ac225 in older patients with untreated acute myeloid leukemia
    Meeting Abstract

    Jurcic, J. G.; Levy, M.; Park, J.; Ravandi, F.; Perl, A.; Pagel, J.; Smith, B. D.; Orozco, J.; Estey, E.; Kantarjian, H.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • Next generation chimeric antigen receptor (CAR) T cells
    Meeting Abstract

    Brentjens, R.
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save